Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Distinct effects of anti-tumor necrosis factor combined therapy on TH1/TH2 balance in rheumatoid arthritis patients.

Herman S, Zurgil N, Machlav S, Shinberg A, Langevitz P, Ehrenfeld M, Deutsch M.

Clin Vaccine Immunol. 2011 Jul;18(7):1077-82. doi: 10.1128/CVI.00061-11. Epub 2011 May 18.

2.

Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients.

Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M.

Clin Exp Rheumatol. 2008 Mar-Apr;26(2):317-23.

PMID:
18565255
3.

Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients.

Kapetanovic MC, Saxne T, Nilsson JA, Geborek P.

Rheumatology (Oxford). 2007 Apr;46(4):608-11. Epub 2006 Nov 18.

PMID:
17114801
4.

Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.

Xinqiang S, Fei L, Nan L, Yuan L, Fang Y, Hong X, Lixin T, Juan L, Xiao Z, Yuying S, Yongzhi X.

Biomed Pharmacother. 2010 Sep;64(7):463-71. doi: 10.1016/j.biopha.2010.01.007. Epub 2010 Feb 25.

PMID:
20359858
5.
6.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

PMID:
11961174
7.

Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.

Hildner K, Finotto S, Becker C, Schlaak J, Schirmacher P, Galle PR, Märker-Hermann E, Neurath MF.

Clin Exp Immunol. 1999 Oct;118(1):137-46.

8.

Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.

Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.

J Rheumatol. 2000 May;27(5):1128-35.

PMID:
10813277
9.

Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.

Aeberli D, Seitz M, Jüni P, Villiger PM.

Rheumatology (Oxford). 2005 Feb;44(2):172-5. Epub 2004 Oct 27.

PMID:
15509629
10.

Differential gene expression profiles may differentiate responder and nonresponder patients with rheumatoid arthritis for methotrexate (MTX) monotherapy and MTX plus tumor necrosis factor inhibitor combined therapy.

Oliveira RD, Fontana V, Junta CM, Marques MM, Macedo C, Rassi DM, Passos GA, Donadi EA, Louzada-Junior P.

J Rheumatol. 2012 Aug;39(8):1524-32. doi: 10.3899/jrheum.120092. Epub 2012 Jul 1.

PMID:
22753658
11.

Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.

van der Heijden JW, Assaraf YG, Gerards AH, Oerlemans R, Lems WF, Scheper RJ, Dijkmans BA, Jansen G.

Scand J Rheumatol. 2014;43(1):9-16. doi: 10.3109/03009742.2013.797490. Epub 2013 Aug 30.

PMID:
23987246
12.

Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis.

Seriolo B, Paolino S, Sulli A, Ferretti V, Cutolo M.

Ann N Y Acad Sci. 2006 Jun;1069:420-7.

PMID:
16855169
13.

Reduced expression of the regulatory CD4+ T cell subset is related to Th1/Th2 balance and disease severity in rheumatoid arthritis.

Yudoh K, Matsuno H, Nakazawa F, Yonezawa T, Kimura T.

Arthritis Rheum. 2000 Mar;43(3):617-27.

15.
16.
18.
19.

A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis.

Ma MH, Kingsley GH, Scott DL.

Rheumatology (Oxford). 2010 Jan;49(1):91-8. doi: 10.1093/rheumatology/kep331. Epub 2009 Nov 16. Review.

PMID:
19917618
20.

Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate.

Varani K, Massara A, Vincenzi F, Tosi A, Padovan M, Trotta F, Borea PA.

Arthritis Rheum. 2009 Oct;60(10):2880-91. doi: 10.1002/art.24794.

Supplemental Content

Support Center